| Ms Judith Mathilda Lindenfelser, | |
|
16635 Centerfield Dr, Suite 200, Eagle River, AK 99577-7719 | |
| (907) 694-0493 | |
| (907) 694-0933 |
| Full Name | Ms Judith Mathilda Lindenfelser |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 16635 Centerfield Dr, Eagle River, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528218302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 338 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Judith Mathilda Lindenfelser, 16635 Centerfield Dr, Suite 200, Eagle River, AK 99577-7719 Ph: (907) 694-0493 | Ms Judith Mathilda Lindenfelser, 16635 Centerfield Dr, Suite 200, Eagle River, AK 99577-7719 Ph: (907) 694-0493 |
News Archive
The regulation of the biological fixation of nitrogen in hydric stress conditions varies with the different species of legume plants studied.
New research from University of Alabama at Birmingham indicates that patients with heart failure who have low to low-normal serum potassium levels are at increased risk of death.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.
Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms' tumors.
The fight to treat cancer and eradicate tumors will likely benefit from a new set of treatments if early development phases continue to show promise, according to Kalorama Information. The healthcare market research publisher stated that gene therapies that are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor.
› Verified 9 days ago
Courtney Marie Kujansuu, MSN, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4150 Elkhorn Dr, Eagle River, AK 99577 Phone: 309-370-2630 |